Bequests and Planned Gifts ›
What’s New
Research and Patient Care
September 15, 2024
A landmark trial co-led by Dana-Farber showed that about half of patients with metastatic melanoma treated with a combination immunotherapy survive cancer-free for 10 years or more.
more ›
August 21, 2024
The FDA approved belzutifan for adult patients with advanced renal cell carcinoma following a Dana-Farber-led clinical trial.
more ›